In a filing, Gilead Sciences, Inc revealed its Officer ANDREW DICKINSON acquired Company’s shares for reported $0.78 million on Dec 16 ’24. In the deal valued at $91.96 per share,8,500 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Dickinson Andrew D sold 248,645 shares, generating $23,065,271 in total proceeds. Upon selling the shares at $92.76, the Chief Financial Officer now owns 138,919 shares.
Before that, Parsey Merdad sold 164,211 shares. Gilead Sciences, Inc shares valued at $15,094,013 were divested by the Chief Medical Officer at a price of $91.92 per share. As a result of the transaction, Parsey Merdad now holds 80,801 shares, worth roughly $7.44 million.
A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. Citigroup began covering GILD with “Buy” recommendation on November 14, 2024. Maxim Group revised its rating on November 08, 2024. It rated GILD as “a Hold” which previously was an “a Buy”.
Price Performance Review of GILD
On Monday, Gilead Sciences, Inc [NASDAQ:GILD] saw its stock jump 0.21% to $92.05. Over the last five days, the stock has gained 1.61%. Gilead Sciences, Inc shares have risen nearly 13.63% since the year began. Nevertheless, the stocks have risen 12.56% over the past one year. While a 52-week high of $98.90 was reached on 11/11/24, a 52-week low of $62.07 was recorded on 05/31/24. SMA at 50 days reached $89.95, while 200 days put it at $76.61.
Levels Of Support And Resistance For GILD Stock
The 24-hour chart illustrates a support level at 91.55, which if violated will result in even more drops to 91.04. On the upside, there is a resistance level at 92.91. A further resistance level may holdings at 93.76. The Relative Strength Index (RSI) on the 14-day chart is 53.10, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.27%. Stochastics %K at 53.24% indicates the stock is a holding.
How much short interest is there in Gilead Sciences, Inc?
A steep rise in short interest was recorded in Gilead Sciences, Inc stocks on 2024-11-29, growing by 5.67 million shares to a total of 23.41 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 17.74 million shares. There was a rise of 24.21%, which implies that there is a positive sentiment for the stock.
